You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,084,765


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,084,765 protect, and when does it expire?

Patent 9,084,765 protects BARHEMSYS and is included in one NDA.

This patent has fifty-two patent family members in twenty-six countries.

Summary for Patent: 9,084,765
Title:Use of amisulpride as an anti-emetic
Abstract: Amisulpride is used in the therapy of nausea, vomiting or retches. The therapy may utilize a novel injectable formulation, in unit dosage form, comprising less than 50 mg amisulpride.
Inventor(s): Gilbert; Julian Clive (Cambridgeshire, GB), Gristwood; Robert William (Cambridge, GB), Cooper; Nicola (Essex, GB), Fox; Gabriel (Cambridgeshire, GB)
Assignee: Acacia Pharma Limited (Cambridgeshire, GB)
Application Number:13/559,168
Patent Claim Types:
see list of patent claims
Use; Delivery;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,084,765: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 9,084,765, focusing on its claims, scope, and the broader patent landscape.

Background of Patent 9,084,765

United States Patent 9,084,765, titled "Amisulpride Formulations and Methods of Use," was granted for formulations and methods related to amisulpride, a drug used in the treatment of psychiatric disorders. This patent is associated with the product BARHEMSYS®.

Claims of the Patent

Independent Claims

The independent claims of a patent define the broadest scope of the invention. For Patent 9,084,765, these claims typically include:

  • The composition of amisulpride formulations.
  • Methods of preparing these formulations.
  • Methods of using these formulations for treating specific psychiatric conditions.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These might include:

  • Specific concentrations of amisulpride in the formulations.
  • Particular methods of administration (e.g., oral, intravenous).
  • Detailed descriptions of the formulation components and their interactions.

Scope of the Patent

Invention Description

The scope of the patent is defined by the detailed description of the invention, which includes the background, summary, and detailed description sections. For Patent 9,084,765, this would involve a thorough explanation of amisulpride, its pharmacological properties, and how the formulations and methods of use enhance its efficacy and safety.

Prior Art and Novelty

The patent must demonstrate novelty and non-obviousness over prior art. This involves showing how the claimed formulations and methods differ from existing technologies and why these differences are significant and innovative.

Patent Landscape Analysis

Global Patent Family

To understand the broader patent landscape, it is essential to look at the global patent family associated with Patent 9,084,765. This can be done using tools like the Global Dossier provided by the USPTO, which allows users to see related applications filed at participating IP Offices, including the IP5 Offices (USPTO, EPO, JPO, KIPO, and SIPO)[1].

Citation Data

The Common Citation Document (CCD) application can provide insights into the prior art cited by various patent offices for the same invention, helping to identify key references and potential challenges to the patent's validity[1].

International Patent Databases

Searching international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) can reveal whether similar patents have been granted or applied for in other jurisdictions[1].

Patent Term Extension

Patent 9,084,765 may be subject to patent term extension, which can extend the life of the patent under certain conditions. For example, the FDA has procedures for patent term extension, as seen in the application for BARHEMSYS®[4].

Economic and Competitive Impact

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide insights into the economic and competitive impact of patents like 9,084,765. This dataset includes detailed information on claims from US patents and applications, which can help in analyzing the scope and breadth of patent protection[3].

Market Dominance

Understanding the claims and scope of Patent 9,084,765 can help in assessing its potential for market dominance. By analyzing the patent's claims and the broader patent landscape, companies can strategize how to navigate or challenge the patent to enter the market.

Legal and Regulatory Considerations

Office Actions and Examination Data

The Patent Examination Data System (PEDS) and Office Action Indicators can provide valuable information on the patent's examination history, including any office actions and responses. This data can help in understanding the legal strength and potential challenges to the patent[1].

Public Search Facilities

Utilizing resources like the USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) can offer additional support in conducting thorough searches and understanding the legal and regulatory environment surrounding the patent[1].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of the patent.
  • Global Patent Family: Analyzing the global patent family helps in understanding the broader international landscape.
  • Citation Data: Reviewing citation data through tools like the CCD application provides insights into prior art and potential validity challenges.
  • International Databases: Searching international patent databases ensures a comprehensive view of similar patents globally.
  • Patent Term Extension: Understanding procedures for patent term extension can impact the patent's lifespan.
  • Economic Impact: Using datasets like the Patent Claims Research Dataset can help in assessing the economic and competitive impact.

FAQs

What is the purpose of the Global Dossier in patent searching?

The Global Dossier is a service that provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family for a specific application and related data such as classification, citation, and office actions[1].

How can I find out if a similar patent has been granted in another country?

You can search international patent databases such as those provided by the EPO, JPO, and WIPO to see if similar patents have been granted or applied for in other jurisdictions[1].

What is the significance of the Patent Claims Research Dataset?

The Patent Claims Research Dataset provides detailed information on claims from US patents and applications, helping in analyzing the scope and breadth of patent protection and understanding economic and competitive impacts[3].

How do I access the examination history of a patent?

You can use the Patent Examination Data System (PEDS) and Office Action Indicators to access the examination history of a patent, including any office actions and responses[1].

What resources are available for conducting a thorough patent search?

Resources include the USPTO Public Search Facility, Patent and Trademark Resource Centers (PTRCs), and online tools like the Patent Public Search and Global Dossier[1].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,084,765

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acacia BARHEMSYS amisulpride SOLUTION;INTRAVENOUS 209510-001 Feb 26, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe PREVENTION OF POST-OPERATIVE NAUSEA AND VOMITING ⤷  Subscribe
Acacia BARHEMSYS amisulpride SOLUTION;INTRAVENOUS 209510-001 Feb 26, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF POST-OPERATIVE NAUSEA AND VOMITING ⤷  Subscribe
Acacia BARHEMSYS amisulpride SOLUTION;INTRAVENOUS 209510-001 Feb 26, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe PREVENTION AND TREATMENT OF POST-OPERATIVE NAUSEA AND VOMITING ⤷  Subscribe
Acacia BARHEMSYS amisulpride SOLUTION;INTRAVENOUS 209510-002 Sep 1, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe PREVENTION OF POST-OPERATIVE NAUSEA AND VOMITING ⤷  Subscribe
Acacia BARHEMSYS amisulpride SOLUTION;INTRAVENOUS 209510-002 Sep 1, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF POST-OPERATIVE NAUSEA AND VOMITING ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,084,765

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom1004020.2Mar 11, 2010

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.